MDMX公司
调节器
生物
体内
表型
抑制器
细胞生物学
细胞凋亡
DNA损伤
胚胎
癌症研究
平方毫米
突变体
DNA
基因
遗传学
作者
Rick Avery Finch,Dorit B. Donoviel,David Potter,Min Shi,Amy Z. Fan,Deon D. Freed,Ching-Yun Wang,Brian Zambrowicz,Ramiro Ramirez-Solis,Arthur T. Sands,Nan Zhang
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2002-06-01
卷期号:62 (11): 3221-5
被引量:86
摘要
Regulation of p53 protein activity is required for normal embryogenesis, tumor suppression, and cellular response to DNA damage. Here we report that loss of mdmx, a p53-binding protein, results in midgestational embryo lethality, a phenotype that is completely rescued by the absence of p53. Mice homozygous for both mdmx and p53 null mutations are viable and appear developmentally normal. Fibroblasts derived from embryos with reduced mdmx expression demonstrate a decreased growth rate and increased UV-induced apoptosis compared with wild-type cells and contain elevated levels of p53 and several p53 target proteins including the proapoptotic bax protein. These observations demonstrate that mdmx functions as a critical negative regulator of p53 in vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI